UIMC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.340100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.442200E-01
Normal-vs-Stage2
6.428400E-02
Normal-vs-Stage3
7.271600E-02
Normal-vs-Stage4
4.334800E-01
Stage1-vs-Stage2
5.716800E-01
Stage1-vs-Stage3
3.098000E-02
Stage1-vs-Stage4
8.416000E-01
Stage2-vs-Stage3
9.146200E-02
Stage2-vs-Stage4
5.180600E-01
Stage3-vs-Stage4
8.266300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.168400E-02
Normal-vs-AfricanAmerican
9.459500E-02
Normal-vs-Asian
2.204400E-01
Caucasian-vs-AfricanAmerican
2.387200E-01
Caucasian-vs-Asian
6.414800E-01
AfricanAmerican-vs-Asian
7.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.117900E-02
Normal-vs-Female
5.770200E-02
Male-vs-Female
9.581400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.636000E-01
Normal-vs-Age(41-60Yrs)
1.697210E-01
Normal-vs-Age(61-80Yrs)
3.140500E-02
Normal-vs-Age(81-100Yrs)
3.425200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.188200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.147600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.771200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.041090E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.120800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.069200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.649600E-02
Normal-vs-Daily Drinker
1.584810E-01
Normal-vs-Weekly Drinker
8.211900E-02
Normal-vs-Occasional Drinker
6.151800E-02
Normal-vs-Social Drinker
1.664000E-01
Non Drinker-vs-Daily Drinker
6.440600E-01
Non Drinker-vs-Weekly Drinker
6.422000E-01
Non Drinker-vs-Occasional Drinker
7.107200E-01
Non Drinker-vs-Social Drinker
3.113400E-01
Daily Drinker-vs-Weekly Drinker
4.225200E-01
Daily Drinker-vs-Occasional Drinker
9.097200E-01
Daily Drinker-vs-Social Drinker
5.985200E-01
Weekly Drinker-vs-Occasional Drinker
4.104200E-01
Weekly Drinker-vs-Social Drinker
1.809600E-01
Occasional Drinker-vs-Social Drinker
4.421200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.045580E-01
Normal-vs-Grade 2
1.218060E-03
Normal-vs-Grade 3
3.597900E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.122400E-01
Grade 1-vs-Grade 3
8.223900E-02
Grade 1-vs-Grade 4
1.045580E-01
Grade 2-vs-Grade 3
6.336600E-01
Grade 2-vs-Grade 4
1.218060E-03
Grade 3-vs-Grade 4
3.597900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.260000E-02
Normal-vs-NonDiabetic
5.526300E-02
Diabetic-vs-NonDiabetic
9.228200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.445200E-01
Normal-vs-NoPancreatitis
3.949900E-02
Pancreatitis-vs-NoPancreatitis
9.672400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.071250E-01
Normal-vs-N1
4.517900E-02
N0-vs-N1
6.117200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.794400E-02
Normal-vs-TP53-NonMutant
9.821800E-02
TP53-Mutant-vs-TP53-NonMutant
9.000200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
